Nissen-Meyer R
Norwegian Radium Hospital, Oslo.
Ann Oncol. 1991 May;2(5):343-6. doi: 10.1093/oxfordjournals.annonc.a057952.
Between November 1957 and December 1963, 169 premenopausal and 177 postmenopausal patients were included in a randomized clinical trial. In the experimental group ovarian irradiation was given shortly after mastectomy. In the control group ovarian irradiation was planned for the time of first recurrence. The last published follow-up in 1974 [1] revealed a significant effect on disease-free survival both in premenopausal and postmenopausal patients. The latest results from a follow-up conducted in 1989 demonstrate a significant effect also on crude survival in both age groups. As expected, long-term effects are observed exclusively in the premenopausal cohort.
1957年11月至1963年12月期间,169名绝经前患者和177名绝经后患者被纳入一项随机临床试验。在实验组中,乳房切除术后不久即进行卵巢照射。在对照组中,计划在首次复发时进行卵巢照射。1974年发表的最后一次随访结果[1]显示,绝经前和绝经后患者的无病生存期均有显著影响。1989年进行的随访最新结果表明,两个年龄组的总生存率也有显著影响。正如预期的那样,仅在绝经前队列中观察到长期影响。